All Stories

  1. Cost-effectiveness of comprehensive geriatric assessment: systematic review of economic evaluations
  2. The Effectiveness of Exercise Rehabilitation or Prehabilitation in Cancer Survivors: A Protocol for Systematic Review and Meta-Analysis
  3. Health-economic challenges for new Alzheimer’s disease treatments
  4. Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland
  5. Value‐based prices of emerging disease‐modifying therapies for Alzheimer's disease in 174 countries: a cost‐effectiveness and threshold analysis
  6. Economic evaluations of strategies targeting pre‐diagnosis dementia populations: A systematic review
  7. Accounting for inequality in dementia prevention programmes
  8. Estimating the Future Health and Social Care Costs of Alzheimer's Disease Dementia in the UK: Impact of Disease Modifying Therapy Efficacy, Uptake, and Care Model – A Scenario Modelling Study
  9. Development of an objective assessment tool for appraising reporting quality of economic evaluations with the Consolidated Health Economic Evaluations Reporting Standards 2022: The CHEERS framework
  10. Evaluating the Cost-Effectiveness of Comprehensive Geriatric Assessment: Protocol for a Systematic Review of Economic Evaluations
  11. Access of medication review for people living with dementia: An analysis of inequality using Swedish register data
  12. Dementia prevention requires moving beyond individual choice: the costs of effort and time intersect with social determinants of health
  13. Valuation of the Alzheimer’s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile
  14. Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework
  15. Economic evaluations  of strategies targeting pre-diagnosis dementia  populations: Protocol for a systematic review
  16. Extension and external validation of mapping between the Mini‐Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease
  17. The associations between multimorbidity, healthcare resource utilisation and costs in individuals with Alzheimer's disease dementia
  18. Support, Monitoring and Reminder Technology for Mild Dementia (SMART4MD) for people with mild cognitive impairment and their informal caregivers: a cost-effectiveness analysis (Preprint)
  19. The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
  20. Economic evaluations  of strategies targeting pre-diagnosis dementia  populations: Protocol for a systematic review
  21. Home‐Based Comprehensive Geriatric Assessment for Community‐Dwelling, At‐Risk, Frail Older Adults: A Systematic Review and Meta‐Analysis
  22. SENSE-Cog Residential Care: hearing and vision support for residents with dementia in long-term care in Ireland—protocol for a pilot cluster-randomised controlled trial
  23. Evaluating the Cost-Effectiveness of Comprehensive Geriatric Assessment: Protocol for a Systematic Review of Economic Evaluations
  24. Life span policies and macroeconomic transition will help the 21st‐century brain health revolution in developing countries
  25. Investing in equitable healthy aging: Why Africa must reform social pension schemes to improve Alzheimer's disease and dementia outcomes
  26. Economic evaluations  of strategies targeting pre-diagnosis dementia  populations: Protocol for a systematic review
  27. Dementia risk reduction in the African context: Multi‐national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa‐FINGERS project)
  28. Cost-effectiveness of hearing and vision support for residents with dementia in long-term care in Ireland: A Health Economic Analysis Plan (HEAP) for a simulation model for the SENSE-Cog Care feasibility trial
  29. The cost effectiveness of early assessment and intervention by a dedicated health and social care professional team for older adults in the emergency department compared to treatment-as-usual: Economic evaluation of the OPTI-MEND trial
  30. Navigating the future of Alzheimer’s care in Ireland - a service model for disease-modifying therapies in small and medium-sized healthcare systems
  31. Who should pay the bill for the mental health crisis in Africa?
  32. Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
  33. Measuring the success of programmes of care for people living with dementia: a protocol for consensus building with consumers to develop a set of Core Outcome Measures for Improving Care (COM-IC)
  34. Dementia research in Ireland: What should we prioritise?
  35. SENSE-Cog Residential Care: Hearing and vision support for residents with dementia in long-term care in Ireland: Protocol for a pilot cluster randomised controlled trial
  36. Navigating the future of Alzheimer's care in Ireland - A service model for disease-modifying therapies in small and medium-sized healthcare systems
  37. A Physiotherapy-Led Transition to Home Intervention for Older Adults Following Emergency Department Discharge: A Pilot Feasibility Randomised Controlled Trial (ED PLUS)
  38. Geriatric assessment for older people with cancer: policy recommendations
  39. Association Between Neuroticism and Dementia on Healthcare Use: A Multi-Level Analysis Across 27 Countries from The Survey of Health, Ageing and Retirement in Europe (SHARE)
  40. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis
  41. Early assessment and intervention by a dedicated health and social care professional team in the emergency department in older adults compared to treatment-as-usual: Health Economic Analysis Plan for within-trial cost effectiveness analysis
  42. An Overview of Systematic Reviews and Meta-Analyses on the Effect of Medication Interventions Targeting Polypharmacy for Frail Older Adults
  43. A physiotherapy-led transition to home intervention for older adults following Emergency Department discharge: a pilot feasibility randomised controlled trial
  44. Real World Outcomes, Healthcare Utilisation and Costs of Alzheimer's Disease in England
  45. Is There Evidence of an Association Between Acute Health Care Utilization and Function in Older Adults Over Time? A Population-Based Cohort Study
  46. Comparison of published core outcome sets with outcomes recommended in regulatory guidance from the US Food and Drug Administration and European Medicines Agency: cross sectional analysis
  47. Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: A Systematic Review of Economic Evaluations
  48. Cost‐effectiveness of clinical interventions for delirium: A systematic literature review of economic evaluations
  49. The effectiveness of interventions to reduce adverse outcomes among older adults following Emergency Department discharge: umbrella review
  50. The Scottish Brain Health Service Model: Rationale and Scientific Basis for a National Care Pathway of Brain Health Services in Scotland
  51. Healthcare costs of dementia diseases before, during and after diagnosis: Longitudinal analysis of 17 years of Swedish register data
  52. A physiotherapy-led transition to home intervention for older adults following emergency department discharge: protocol for a pilot feasibility randomised controlled trial
  53. Representation of published core outcome sets for research in regulatory guidance: protocol
  54. Strategies to enhance routine physical activity in care home residents: the REACH research programme including a cluster feasibility RCT
  55. Impact of assessment and intervention by a health and social care professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults: A randomised controlled trial
  56. The Effectiveness of Community Neurorehabilitation for Persons with an Acquired Brain Injury: Protocol for a Systematic Review and Meta-Analysis
  57. Representation of published core outcome sets for research in regulatory guidance: protocol
  58. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease
  59. Representation of published core outcome sets for research in regulatory guidance: protocol
  60. The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)
  61. Effectiveness of interventions to reduce adverse outcomes among older adults following emergency department discharge: Protocol for an overview of systematic reviews
  62. Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations
  63. Perceptions of European ME/CFS Experts Concerning Knowledge and Understanding of ME/CFS among Primary Care Physicians in Europe: A Report from the European ME/CFS Research Network (EUROMENE)
  64. The effectiveness of community neurorehabilitation for persons with an acquired brain injury: protocol for a systematic review
  65. The economic cost of delirium: A systematic review and quality assessment
  66. Building clinically relevant outcomes across the Alzheimer's disease spectrum
  67. A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE)
  68. Neuropsychological rehabilitation interventions for people with an acquired brain injury. A protocol for a systematic review of economic evaluation
  69. A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)
  70. Dementia in Latin America: Paving the way toward a regional action plan
  71. Neuropsychological rehabilitation interventions for people with an acquired brain injury and their caregivers. A protocol for a systematic review of economic evaluation
  72. A protocol for the establishment and evaluation of an older adult stakeholder panel for health services research
  73. Cost-effectiveness of brief structured interventions to discontinue long-term benzodiazepine use: an economic analysis alongside a randomised controlled trial
  74. Effectiveness of interventions to reduce adverse outcomes among older adults following emergency department discharge: Protocol for an overview of systematic reviews
  75. The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE)
  76. A protocol for the establishment and evaluation of an older adult stakeholder panel for health services research
  77. The impact of SARS‐CoV‐2 in dementia across Latin America: A call for an urgent regional plan and coordinated response
  78. Computerised cognitive–behavioural therapy for depression in adolescents: 12-month outcomes of a UK randomised controlled trial pilot study
  79. Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union
  80. A randomised controlled trial exploring the impact of a dedicated health and social care professionals team in the emergency department on the quality, safety, clinical and cost-effectiveness of care for older adults: a study protocol
  81. Randomised controlled trial and economic evaluation of a task-based weight management group programme
  82. Trends in healthcare cover and healthcare use for older adults in Ireland during the austerity years of 2009 to 2016
  83. PATCH: posture and mobility training for care staff versus usual care in care homes: study protocol for a randomised controlled trial
  84. 50Determinants in Older Adults Who Frequently Attend the Emergency Department
  85. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
  86. Exposure to nature gardens has time-dependent associations with mood improvements for people with mid- and late-stage dementia: Innovative practice
  87. Improving pregnancy outcome in obese women: the UK Pregnancies Better Eating and Activity randomised controlled Trial
  88. Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression
  89. An examination of the nutritional intake and anthropometric status of individuals with intellectual disabilities: Results from the SOPHIE study
  90. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
  91. A comparison of physical activity, physical fitness levels, BMI and blood pressure of adults with intellectual disability, who do and do not take part in Special Olympics Ireland programmes: Results from the SOPHIE study
  92. Computerised cognitive–behavioural therapy for depression in adolescents: feasibility results and 4-month outcomes of a UK randomised controlled trial
  93. Cost-Effectiveness of Interventions for the Treatment of Dementia Disorders
  94. Acknowledgement of referees, 2016
  95. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme – a randomised controlled trial and economic evaluation
  96. Are Non-Pharmacological Interventions Effective in Reducing Drug Use and Criminality? A Systematic and Meta-Analytical Review with an Economic Appraisal of These Interventions
  97. Social Stories in mainstream schools for children with autism spectrum disorder: a feasibility randomised controlled trial
  98. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages – a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation
  99. Erratum to: CASPER plus (CollAborative care in screen-positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial
  100. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis
  101. Social Stories™ to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled tria...
  102. People with intellectual disability and their families perspectives of Special Olympics Ireland: Qualitative findings from the SOPHIE study
  103. The feasibility and acceptability of using the Mother-Generated Index (MGI) as a Patient Reported Outcome Measure in a randomised controlled trial of maternity care
  104. Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysis
  105. Self-hypnosis for intrapartum pain management in pregnant nulliparous women: a randomised controlled trial of clinical effectiveness
  106. BMC Pregnancy and Childbirth reviewer acknowledgement 2014
  107. Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
  108. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial
  109. Computerised cognitive behaviour therapy for depression in adolescents: study protocol for a feasibility randomised controlled trial
  110. Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools